Last reviewed · How we verify
AZD5718 tablet, Formulation D
At a glance
| Generic name | AZD5718 tablet, Formulation D |
|---|
| Sponsor | AstraZeneca |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.